Antonella Cromi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antonella Cromi has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Fabio Ghezzi
University of Insubria, 'Filippo Del Ponte' Hospital, Department of Obstetrics and Gynecology, Varese, Italy
19 shared publications - Stefano Uccella
Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, 37126 Verona, Italy
10 shared publications - Maurizio Serati
Department of Obstetrics and Gynaecology, Del Ponte Hospital, University of Insubria, 21100 Varese, Italy
9 shared publications Pierfrancesco Bolis
8 shared publications- Giorgio Bogani
Gynaecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy
5 shared publications - Edoardo Di Naro
Department of Interdisciplinary Medicine (DIM), Obstetrics and Gynecology Unit, University of Bari “Aldo Moro”, Piazza Giulio Cesare 11, 70124 Bari, Italy
4 shared publications
Latest Publications
- 1 September 2018
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 73 (9) , 520-522
Laparoscopic vs Transvaginal Cuff Closure After Total Laparoscopic Hysterectomy: A Randomized Trial by the Italian Society of Gynecologic Endoscopy
- 1 September 2018
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 73 (9) , 520-522
Laparoscopic vs Transvaginal Cuff Closure After Total Laparoscopic Hysterectomy: A Randomized Trial by the Italian Society of Gynecologic Endoscopy
- 14 November 2014
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 28 (18) , 2201-2206
Provider contribution to an episiotomy risk model
Objective: The extent to which the observed variation in episiotomy rates can be attributed to individual practitioners is not known. We sought to analyze the contribution of the attending midwife to a risk model for episiotomy. Study design: We prospectively collected data on 736 consecutive vaginal deliveries in nulliparas at a tertiary maternity hospital. The study measures the impact of the attending midwife on the decision to perform an episiotomy, controlling for a host of patient and clinical characteristics. Midwife effect is evaluated in terms of its overall contribution to the explanatory power of logistic regression model. Results: The overall rate of episiotomy in primiparas was 40.6%. Individual midwife episiotomy rate ranged from 5.6% to 73.9% (p < 0.0001). After controlling for confounding factors with logistic regression, maternal age ≥35 years (OR 1.61, 95%CI: 1.02–2.52), vacuum extraction (OR 26.88, 95%CI: 2.57–280.7), fundal pressure (OR 62.90, 95%CI: 18.39–214.98), second-stage duration (OR 2.24, 95%CI: 1.53–3.28), and the individual midwife were all associated with episiotomy use. The midwife attending the birth and fundal pressure provided the greatest explanatory power of the model. Conclusions: The attending provider adds a significant independent effect to the episiotomy risk model. This has implications for both practice and research in this clinical area.
- 14 November 2014
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 28 (18) , 2201-2206
Provider contribution to an episiotomy risk model
Objective: The extent to which the observed variation in episiotomy rates can be attributed to individual practitioners is not known. We sought to analyze the contribution of the attending midwife to a risk model for episiotomy. Study design: We prospectively collected data on 736 consecutive vaginal deliveries in nulliparas at a tertiary maternity hospital. The study measures the impact of the attending midwife on the decision to perform an episiotomy, controlling for a host of patient and clinical characteristics. Midwife effect is evaluated in terms of its overall contribution to the explanatory power of logistic regression model. Results: The overall rate of episiotomy in primiparas was 40.6%. Individual midwife episiotomy rate ranged from 5.6% to 73.9% (p < 0.0001). After controlling for confounding factors with logistic regression, maternal age ≥35 years (OR 1.61, 95%CI: 1.02–2.52), vacuum extraction (OR 26.88, 95%CI: 2.57–280.7), fundal pressure (OR 62.90, 95%CI: 18.39–214.98), second-stage duration (OR 2.24, 95%CI: 1.53–3.28), and the individual midwife were all associated with episiotomy use. The midwife attending the birth and fundal pressure provided the greatest explanatory power of the model. Conclusions: The attending provider adds a significant independent effect to the episiotomy risk model. This has implications for both practice and research in this clinical area.
- 1 October 2014
- Vol. 34 (10) , 5703-8
A prospective case-control study on the impact of neoadjuvant chemotherapy on surgery-related outcomes of laparoscopic radical hysterectomy.
To investigate whether perioperative outcomes of class III/type C laparoscopic radical hysterectomy (LRH) for cervical cancer (CC) are influenced by neoadjuvant chemotherapy (NACT). Data of consecutive patients, affected by locally advanced-stage CC, undergoing NACT plus LRH were matched 1:2 with consecutive patients, affected by early-stage CC who underwent LRH without NACT. Twenty and 40 patients underwent NACT with LRH and LRH aIone, respectively. Demographic characteristics were balanced between groups. Number of lymph nodes yielded, parametrial width and length of vaginal cuff were not influenced by preoperative administration of NACT. Patients undergoing NACT plus LRH experienced slightly higher blood loss (225 vs. 200 ml; p=0.05) than patients in the control group, but had a similar operative time and length of hospital stay. No between-group differences in transfusion and complications rates were observed (p>0.2). The administration of NACT does not affect the surgery-related outcomes of LRH.
- 1 October 2014
- Vol. 34 (10) , 5703-8
A prospective case-control study on the impact of neoadjuvant chemotherapy on surgery-related outcomes of laparoscopic radical hysterectomy.
To investigate whether perioperative outcomes of class III/type C laparoscopic radical hysterectomy (LRH) for cervical cancer (CC) are influenced by neoadjuvant chemotherapy (NACT). Data of consecutive patients, affected by locally advanced-stage CC, undergoing NACT plus LRH were matched 1:2 with consecutive patients, affected by early-stage CC who underwent LRH without NACT. Twenty and 40 patients underwent NACT with LRH and LRH aIone, respectively. Demographic characteristics were balanced between groups. Number of lymph nodes yielded, parametrial width and length of vaginal cuff were not influenced by preoperative administration of NACT. Patients undergoing NACT plus LRH experienced slightly higher blood loss (225 vs. 200 ml; p=0.05) than patients in the control group, but had a similar operative time and length of hospital stay. No between-group differences in transfusion and complications rates were observed (p>0.2). The administration of NACT does not affect the surgery-related outcomes of LRH.
- 1 July 2014
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 21 (4) , 702-703
Emergency Peripartum Laparoscopic Subtotal Hysterectomy With Transcervical Extraction
- 1 July 2014
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 21 (4) , 702-703
Emergency Peripartum Laparoscopic Subtotal Hysterectomy With Transcervical Extraction
- Open Access
- 1 January 2014
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 7 (1) , 59
Laparoscopic fertility-sparing surgery for early stage ovarian cancer: a single-centre case series and systematic literature review
There is as yet limited evidence about fertility-sparing surgery for early ovarian cancer (EOC) carried out laparoscopically. We sought to analyze recurrence patterns and fertility outcome in a cohort of ovarian cancer patients who underwent fertility-saving laparoscopic surgical staging. We conducted a retrospective analysis of prospectively collected data on all patients undergoing fertility-sparing laparoscopic staging procedures for presumed EOC at a single gynecologic oncology service. Oncologic safety and reproductive outcome were the main outcome measures. The pertinent literature is reviewed. The study cohort consisted of 12 women. Cases included 5 invasive epithelial tumors and 7 nonepithelial tumors. The disease was reclassified to a higher stage in one woman. After a median follow up period of 38 months (range: 14–108), the overall survival was 100% and recurrence-free survival 90.9%. Five (100%) of patients who attempted pregnancy conceived spontaneously. Three of them had uneventful term pregnancy delivering healthy babies. The literature search yielded 62 cases of laparoscopic fertility conserving surgery for ovarian cancer. There were 4 (6.2%) recurrences. Cumulative pregnancy and live birth rate were not estimable as earlier publications lack essential data. Laparoscopic staging may represent a viable option for premenopausal women seeking fertility preservation in the setting of early ovarian cancer. More research is needed to determine whether laparoscopy may offer reproductive benefits to this particular population.
- 1 January 2014
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 7 (1) , 59
Open AccessLaparoscopic fertility-sparing surgery for early stage ovarian cancer: a single-centre case series and systematic literature review
There is as yet limited evidence about fertility-sparing surgery for early ovarian cancer (EOC) carried out laparoscopically. We sought to analyze recurrence patterns and fertility outcome in a cohort of ovarian cancer patients who underwent fertility-saving laparoscopic surgical staging. We conducted a retrospective analysis of prospectively collected data on all patients undergoing fertility-sparing laparoscopic staging procedures for presumed EOC at a single gynecologic oncology service. Oncologic safety and reproductive outcome were the main outcome measures. The pertinent literature is reviewed. The study cohort consisted of 12 women. Cases included 5 invasive epithelial tumors and 7 nonepithelial tumors. The disease was reclassified to a higher stage in one woman. After a median follow up period of 38 months (range: 14–108), the overall survival was 100% and recurrence-free survival 90.9%. Five (100%) of patients who attempted pregnancy conceived spontaneously. Three of them had uneventful term pregnancy delivering healthy babies. The literature search yielded 62 cases of laparoscopic fertility conserving surgery for ovarian cancer. There were 4 (6.2%) recurrences. Cumulative pregnancy and live birth rate were not estimable as earlier publications lack essential data. Laparoscopic staging may represent a viable option for premenopausal women seeking fertility preservation in the setting of early ovarian cancer. More research is needed to determine whether laparoscopy may offer reproductive benefits to this particular population.
- 1 December 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (12) , 773-774
Transumbilical Versus Transvaginal Retrieval of Surgical Specimens at Laparoscopy
- 1 December 2012
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 67 (12) , 773-774
Transumbilical Versus Transvaginal Retrieval of Surgical Specimens at Laparoscopy
- 1 August 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 207 (2) , 125.e1-125.e7
A randomized trial of preinduction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter
- 1 August 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 207 (2) , 125.e1-125.e7
A randomized trial of preinduction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter
- 1 September 2011
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 90 (12) , 1371-1378
Use of an antispasmodic (rociverine) to shorten the length of labor: a randomized, placebo‐controlled trial
Objective. To determine the effectiveness of rociverine, an antispasmodic drug, for reducing the duration of labor among nulliparous women managed according to a standard intrapartum protocol.Design. Randomized controlled trial.Setting. An academic tertiary care hospital.Population. Nulliparae in spontaneous active labor, with cervical dilatation between 3 and 5cm.Methods. Participants were randomly assigned to receive either an intramuscular injection of 20mg rociverine (n=55) or the same volume of saline (n=56).Main Outcome Measure. Cervical dilatation rate (from administration of study drug to full dilatation).Results. Laboring women who received rociverine had faster cervical dilatation than those assigned to placebo (2.43±1.84 vs. 1.85±1.38cm/hour,p=0.03). The time interval from treatment administration to full cervical dilatation was shorter in the rociverine group than in the placebo group (220±125 vs. 278±129min,p=0.04). No difference was found in any other obstetric outcome. No adverse effects have been recorded from rociverine administration.Conclusions. Intrapartum administration of rociverine to nulliparous women may help to reduce the duration of the first stage of labor in a context of uniform labor management.
- 1 September 2011
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 90 (12) , 1371-1378
Use of an antispasmodic (rociverine) to shorten the length of labor: a randomized, placebo‐controlled trial
Objective. To determine the effectiveness of rociverine, an antispasmodic drug, for reducing the duration of labor among nulliparous women managed according to a standard intrapartum protocol.Design. Randomized controlled trial.Setting. An academic tertiary care hospital.Population. Nulliparae in spontaneous active labor, with cervical dilatation between 3 and 5cm.Methods. Participants were randomly assigned to receive either an intramuscular injection of 20mg rociverine (n=55) or the same volume of saline (n=56).Main Outcome Measure. Cervical dilatation rate (from administration of study drug to full dilatation).Results. Laboring women who received rociverine had faster cervical dilatation than those assigned to placebo (2.43±1.84 vs. 1.85±1.38cm/hour,p=0.03). The time interval from treatment administration to full cervical dilatation was shorter in the rociverine group than in the placebo group (220±125 vs. 278±129min,p=0.04). No difference was found in any other obstetric outcome. No adverse effects have been recorded from rociverine administration.Conclusions. Intrapartum administration of rociverine to nulliparous women may help to reduce the duration of the first stage of labor in a context of uniform labor management.
- 1 June 2011
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 8 (6) , 1710-1716
Female Urinary Incontinence at Orgasm: A Possible Marker of a More Severe Form of Detrusor Overactivity. Can Ultrasound Measurement of Bladder Wall Thickness Explain It?
Coital incontinence (CI) during orgasm is a form of urinary incontinence possibly because of detrusor overactivity (DO), as the underlying pathophysiological condition. Women with this symptom usually show a pharmacological lower cure rate than those with DO alone. The ultrasound measurement of the bladder wall thickness (BWT) allows an indirect evaluation of detrusor muscle thickness, giving a potential index of detrusor activity. We wanted to understand if CI at orgasm could be a marker of severity of DO by comparing BWT in women with both DO and CI at orgasm vs. women with DO alone. In addition we aimed to confirm if CI during orgasm is related to antimuscarinics treatment failure. This is a prospective cohort study performed in two tertiary urogynecological referral departments, recruiting consecutive patients seeking treatment for symptomatic DO. All patients were thoroughly assessed including physical examination, urodynamic evaluation, and BWT measurement according to the International Continence Society/International Urogynecological Association and ICI recommendations. Solifenacine 5 mg once daily was then prescribed and follow-up was scheduled to evaluate treatment. Multiple logistic regression (MLR) was performed to identify risk factors for treatment failure. Between September 2007 and March 2010, 31 (22.6%) and 106 (77.4%) women with DO with and without CI at orgasm were enrolled. Women complaining of CI at orgasm had significantly higher BWT than the control group (5.8 ± 0.6 mm vs. 5.2 ± 1.2 mm [P = 0.007]). In patients with CI at orgasm, the nonresponder rate to antimuscarinics was significantly higher than controls (P = 0.01). After MLR, CI at orgasm was the only independent predictor decreasing antimuscarinics efficacy (odds ratio [OR] 3.16 [95% CI 1.22–8.18], P = 0.02). Women with DO and CI at orgasm showed a significantly higher BWT values and worse cure rates than women with DO alone. CI at orgasm could be a marker of a more severe form of DO. Serati M, Salvatore S, Cattoni E, Siesto G, Soligo M, Braga A, Sorice P, Cromi A, Ghezzi F, Cardozo L, and Bolis P. Female urinary incontinence at orgasm: A possible marker of a more severe form of detrusor overactivity. Can ultrasound measurement of bladder wall thickness explain it?.
- 1 June 2011
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 8 (6) , 1710-1716
Female Urinary Incontinence at Orgasm: A Possible Marker of a More Severe Form of Detrusor Overactivity. Can Ultrasound Measurement of Bladder Wall Thickness Explain It?
Coital incontinence (CI) during orgasm is a form of urinary incontinence possibly because of detrusor overactivity (DO), as the underlying pathophysiological condition. Women with this symptom usually show a pharmacological lower cure rate than those with DO alone. The ultrasound measurement of the bladder wall thickness (BWT) allows an indirect evaluation of detrusor muscle thickness, giving a potential index of detrusor activity. We wanted to understand if CI at orgasm could be a marker of severity of DO by comparing BWT in women with both DO and CI at orgasm vs. women with DO alone. In addition we aimed to confirm if CI during orgasm is related to antimuscarinics treatment failure. This is a prospective cohort study performed in two tertiary urogynecological referral departments, recruiting consecutive patients seeking treatment for symptomatic DO. All patients were thoroughly assessed including physical examination, urodynamic evaluation, and BWT measurement according to the International Continence Society/International Urogynecological Association and ICI recommendations. Solifenacine 5 mg once daily was then prescribed and follow-up was scheduled to evaluate treatment. Multiple logistic regression (MLR) was performed to identify risk factors for treatment failure. Between September 2007 and March 2010, 31 (22.6%) and 106 (77.4%) women with DO with and without CI at orgasm were enrolled. Women complaining of CI at orgasm had significantly higher BWT than the control group (5.8 ± 0.6 mm vs. 5.2 ± 1.2 mm [P = 0.007]). In patients with CI at orgasm, the nonresponder rate to antimuscarinics was significantly higher than controls (P = 0.01). After MLR, CI at orgasm was the only independent predictor decreasing antimuscarinics efficacy (odds ratio [OR] 3.16 [95% CI 1.22–8.18], P = 0.02). Women with DO and CI at orgasm showed a significantly higher BWT values and worse cure rates than women with DO alone. CI at orgasm could be a marker of a more severe form of DO. Serati M, Salvatore S, Cattoni E, Siesto G, Soligo M, Braga A, Sorice P, Cromi A, Ghezzi F, Cardozo L, and Bolis P. Female urinary incontinence at orgasm: A possible marker of a more severe form of detrusor overactivity. Can ultrasound measurement of bladder wall thickness explain it?.
- 1 April 2011
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 204 (4) , 338.e1-338.e7
Is transcervical Foley catheter actually slower than prostaglandins in ripening the cervix? A randomized study
- 1 April 2011
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 204 (4) , 338.e1-338.e7
Is transcervical Foley catheter actually slower than prostaglandins in ripening the cervix? A randomized study